And more pharma news updates from Pharmalittle.

Eli Lilly (NYSE:LLY) announced it would appeal a decision by the U.K. health authorities not to recommend the company’s new ...

The UK's state-run health service said Thursday it will not offer two new treatments for Alzheimer's disease, citing high ...